8-KEarnings & ResultsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Oct 27, 2021)

Filed October 27, 2021For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K on October 26, 2021, to report its financial results for the fiscal quarter ended October 2, 2021. The filing primarily directs investors to a press release (Exhibit 99.1) containing the detailed financial outcomes for the period. While the 8-K itself does not provide the specific figures, it serves as the official notification and access point for this crucial earnings information. Investors should refer to the referenced press release for a comprehensive understanding of TMO's performance in the third quarter of 2021, including key financial metrics, revenue drivers, and management commentary. The filing also includes a standard cautionary statement regarding forward-looking information, highlighting potential risks and uncertainties that could impact future results, such as the ongoing COVID-19 pandemic, economic conditions, and the integration of recent acquisitions like PPD, Inc.

Key Highlights

  • 1Thermo Fisher Scientific announced its financial results for the fiscal quarter ended October 2, 2021.
  • 2The official announcement of the quarterly results is provided via a press release (Exhibit 99.1) attached to the 8-K filing.
  • 3The filing serves as the formal disclosure of the company's operational and financial condition for the period.
  • 4Investors are directed to the press release for specific financial data and performance details.
  • 5The report includes a standard cautionary statement about forward-looking statements, outlining potential risks and uncertainties.
  • 6Key factors that could affect future results include the COVID-19 pandemic, economic conditions, and integration of acquisitions, notably PPD, Inc.

Frequently Asked Questions

The specific financial results for the fiscal quarter ended October 2, 2021, are detailed in the press release filed as Exhibit 99.1 to this Form 8-K. You should refer to that document for detailed financial information.

This 8-K filing officially announces Thermo Fisher Scientific's financial results for the third quarter of 2021. It serves as the formal notification and provides access to the earnings press release, which contains the key performance metrics and management's discussion of the results.

No, the 8-K filing itself does not contain the detailed financial figures. It primarily incorporates by reference the press release (Exhibit 99.1) where those results are fully disclosed.

The filing's cautionary statement highlights several risks that could impact future results, including the duration and severity of the COVID-19 pandemic, general economic conditions, technological changes, dependence on customer spending and government funding, international operations, regulatory changes, and the successful integration of acquisitions, such as PPD, Inc.